Why this scientist jumped straight from academia to startup CEO

Alexis Howerton's San Francisco startup is targeting a genetic condition with no FDA-approved treatments.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 23, 2018 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news